Caroline Chapman

5.0k total citations
99 papers, 3.9k citations indexed

About

Caroline Chapman is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology. According to data from OpenAlex, Caroline Chapman has authored 99 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Radiology, Nuclear Medicine and Imaging, 39 papers in Immunology and 27 papers in Oncology. Recurrent topics in Caroline Chapman's work include Monoclonal and Polyclonal Antibodies Research (39 papers), Immunotherapy and Immune Responses (19 papers) and T-cell and B-cell Immunology (18 papers). Caroline Chapman is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (39 papers), Immunotherapy and Immune Responses (19 papers) and T-cell and B-cell Immunology (18 papers). Caroline Chapman collaborates with scholars based in United Kingdom, United States and Malaysia. Caroline Chapman's co-authors include Freda K. Stevenson, J.F.R. Robertson, Alan Murray, Paul Maddison, Celine B. Parsy-Kowalska, Myfanwy B. Spellerberg, John F. R. Robertson, Graham Healey, Andrea Murray and Uğur Şahin and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Caroline Chapman

97 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caroline Chapman United Kingdom 35 1.4k 1.2k 1.2k 913 533 99 3.9k
Serge Jothy Canada 37 2.1k 1.5× 593 0.5× 1.0k 0.9× 1.3k 1.4× 458 0.9× 80 4.8k
Jason Konner United States 31 889 0.6× 478 0.4× 910 0.8× 1.8k 1.9× 525 1.0× 122 4.0k
Marianna Nuti Italy 32 1.8k 1.3× 1.1k 0.9× 1.5k 1.3× 1.6k 1.7× 508 1.0× 132 4.1k
Salvatore Venuta Italy 45 2.2k 1.6× 481 0.4× 1.4k 1.1× 1.6k 1.7× 276 0.5× 137 5.1k
Karen S. Anderson United States 40 2.2k 1.6× 768 0.6× 1.9k 1.6× 1.6k 1.8× 352 0.7× 134 4.9k
Amita Joshi United States 31 840 0.6× 1.1k 0.9× 685 0.6× 820 0.9× 222 0.4× 88 3.0k
Kevin L. Moore United States 37 3.3k 2.4× 921 0.8× 2.9k 2.4× 843 0.9× 321 0.6× 59 8.1k
James L. Murray United States 41 2.0k 1.4× 1.8k 1.5× 1.9k 1.6× 2.6k 2.8× 639 1.2× 176 5.8k
Jean‐Luc Teillaud France 41 2.0k 1.4× 2.2k 1.8× 2.8k 2.3× 1.5k 1.6× 257 0.5× 164 5.7k
David C. James United Kingdom 41 3.9k 2.8× 1.3k 1.1× 1.7k 1.4× 462 0.5× 244 0.5× 127 7.3k

Countries citing papers authored by Caroline Chapman

Since Specialization
Citations

This map shows the geographic impact of Caroline Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Chapman more than expected).

Fields of papers citing papers by Caroline Chapman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Chapman. The network helps show where Caroline Chapman may publish in the future.

Co-authorship network of co-authors of Caroline Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Chapman. A scholar is included among the top collaborators of Caroline Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Chapman. Caroline Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nolan, Christopher C., et al.. (2024). Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value. Breast Cancer Research and Treatment. 206(1). 143–153. 7 indexed citations
2.
Crooks, Colin, Ayan Banerjea, James Jones, et al.. (2023). Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England. Alimentary Pharmacology & Therapeutics. 58(4). 443–452. 7 indexed citations
3.
Bailey, James A., James Jones, Caroline Chapman, et al.. (2023). Sociodemographic variations in the uptake of faecal immunochemical tests in primary care: a retrospective study. British Journal of General Practice. 73(736). e843–e849. 8 indexed citations
4.
Ramracheya, Reshma, Caroline Chapman, Margarita V. Chibalina, et al.. (2018). GLP-1 suppresses glucagon secretion in human pancreatic alpha-cells by inhibition of P/Q-type Ca 2+ channels. Physiological Reports. 6(17). e13852–e13852. 81 indexed citations
5.
Lam, Stephen, Peter Boyle, Graham Healey, et al.. (2011). Early CDT-Lung: An Immunobiomarker Test as an Aid to Early Detection of Lung Cancer. Cancer Prevention Research. 4(7). 1126–1134. 118 indexed citations
6.
Murray, Andrea, Graham Healey, Caroline Chapman, et al.. (2010). Reproducibility of Autoantibody Measurements in Normal Individuals Using the Early CDT-Lung Test. CHEST Journal. 138(4). 242A–242A. 1 indexed citations
7.
Chapman, Caroline, J.F.R. Robertson, Andrea Murray, et al.. (2010). The Presence of Autoantibodies to Tumour-Associated Antigens Can Predate Clinical Diagnosis of Small Cell Lung Cancer. CHEST Journal. 138(4). 775A–775A. 5 indexed citations
8.
Chapman, Caroline, et al.. (2010). Identification of Tumor-Associated Autoantibodies in Small Cell Lung Cancer as Immune Markers of Disease. CHEST Journal. 138(4). 238A–238A. 1 indexed citations
9.
Boyle, Peter, Stephen Lam, Paul Maddison, et al.. (2010). Antigen Positivity in the Early CDT-Lung Test by Stage and Histological Subtype of Lung Cancer. CHEST Journal. 138(4). 727A–727A. 2 indexed citations
10.
Murray, Alan, Caroline Chapman, Graham Healey, et al.. (2010). Technical validation of an autoantibody test for lung cancer. Annals of Oncology. 21(8). 1687–1693. 61 indexed citations
11.
Bryant, Linda, et al.. (2009). High-dose-rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma. Brachytherapy. 9(1). 66–70. 23 indexed citations
12.
Hamid, Umi Marshida Abd, Louise Royle, Radka Saldova, et al.. (2008). A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology. 18(12). 1105–1118. 182 indexed citations
13.
Chapman, Caroline, Alan Murray, J. Chakrabarti, et al.. (2007). Autoantibodies in breast cancer: their use as an aid to early diagnosis. Annals of Oncology. 18(5). 868–873. 218 indexed citations
14.
Chapman, Caroline, et al.. (2007). Two-step method to isolate target recombinant protein from co-purified bacterial contaminant SlyD after immobilised metal affinity chromatography. Journal of Chromatography B. 853(1-2). 314–319. 22 indexed citations
15.
Graves, Cornelia, J.F.R. Robertson, Alan Murray, Michael R. Price, & Caroline Chapman. (2005). Malignancy‐induced autoimmunity to MUC1: initial antibody characterization. Journal of Peptide Research. 66(6). 357–363. 11 indexed citations
16.
Mockridge, C. Ian, Caroline Chapman, Myfanwy B. Spellerberg, David Isenberg, & Freda K. Stevenson. (1996). Use of phage surface expression to analyze regions of human V4-34(VH4-21)-encoded IgG autoantibody required for recognition of DNA: no involvement of the 9G4 idiotope. The Journal of Immunology. 157(6). 2449–2454. 27 indexed citations
17.
Chapman, Caroline, Myfanwy B. Spellerberg, Terry J. Hamblin, & Freda K. Stevenson. (1995). Pattern of usage of the VH4–21 gene by B lymphocytes in a patient with EBV infection indicates ongoing mutation and class switching. Molecular Immunology. 32(5). 347–353. 19 indexed citations
18.
Chapman, Caroline, C. Ian Mockridge, Myfanwy B. Spellerberg, et al.. (1995). Use of a Phage Expression System to Produce Fabs from Human Autoanti‐DNA Antibodies Encoded by the VH4–21 Gene Segment. Annals of the New York Academy of Sciences. 764(1). 576–579.
19.
Stevenson, Freda K., Celia M. Longhurst, Caroline Chapman, et al.. (1993). Utilization of the VH4-21 Gene Segment by Anti-DNA Antibodies from Patients with Systemic Lupus Erythematosus. Journal of Autoimmunity. 6(6). 809–825. 96 indexed citations
20.
Chapman, Caroline, et al.. (1993). Autoanti-red cell antibodies synthesized by patients with infectious mononucleosis utilize the VH4-21 gene segment.. The Journal of Immunology. 151(2). 1051–1061. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Serge Jothy Breakdown of academic impact, for papers by Jason Konner Breakdown of academic impact, for papers by Marianna Nuti Breakdown of academic impact, for papers by Salvatore Venuta Breakdown of academic impact, for papers by Karen S. Anderson Breakdown of academic impact, for papers by Amita Joshi Breakdown of academic impact, for papers by Kevin L. Moore Breakdown of academic impact, for papers by James L. Murray Breakdown of academic impact, for papers by Jean‐Luc Teillaud Breakdown of academic impact, for papers by David C. James
Rankless by CCL
2026